News

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...
GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...
The researchers first tested their hypothesis by delivering ODN directly to the hindbrain of rats. Once treated, the rats ...
Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...
Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...
The booming demand for weight loss jabs may be unsustainable, pharmacists warn. Many more patients are interested in using ...
What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...
Weight loss injections could be key to controlling a chronic condition in thousands of Brits, new research suggests ...
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
While treatments like Ozempic, Mounjaro and Wegovy can provide a helping hand, there’s no magic bullet when it comes to ...
In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who had been on GLP-1 medications for a year.